Company

Agenus Inc

NASDAQ:AGEN

Agenus Inc., (Agenus), formerly Antigenics Inc., is a biotechnology company focused on the development and commercialization of technologies to treat cancers and infectious diseases, based on immunological approaches.

4 stories

Medical technology & services

Agenus shares surge as company secures up to $340M to advance colon cancer trial

By Proactive 13/07

Medical technology & services

Agenus is 'turning cold tumors hot and making CTLA-4 cool again'

By Proactive 06/06/2023

Pharma & Biotech

Agenus partners with Gilead Sciences to develop five immuno-oncology therapies

Agenus will receive a $120 million upfront payment and a $30 million equity investment from Gilead

By Proactive 20/12/2018

Medical technology & services

Agenus maintains “buy” at HCW on heels of CEACAM1 acquisition

By Proactive 20/07/2015